title: Effects of mycophenolate sodium with or without FTY720 in a DA-to-Lewis rat heart transplantation model.
authors.affiliation: Novartis Pharma Research, Novartis Pharma AG, Basel, Switzerland.
authors.forename: Y
authors.initials: Y
authors.lastname: Matsumoto
authors.forename: R P
authors.initials: RP
authors.lastname: Hof
mesh_terms: D000818:Animals; D004195:Disease Models, Animal; D004359:Drug Therapy, Combination; D000068876:Fingolimod Hydrochloride; D006085:Graft Survival / Q000187:drug effects / Q000276:immunology*; D016027:Heart Transplantation / Q000276:immunology*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D009173:Mycophenolic Acid / Q000627:therapeutic use*; D011409:Propylene Glycols / Q000627:therapeutic use*; D051381:Rats; D011917:Rats, Inbred Lew; D011919:Rats, Inbred Strains; D013110:Sphingosine / Q000031:analogs & derivatives; D013997:Time Factors; D014184:Transplantation, Homologous
chemical_list: D007166:Immunosuppressive Agents; D011409:Propylene Glycols; D000068876:Fingolimod Hydrochloride; D009173:Mycophenolic Acid; D013110:Sphingosine